Neopenda

Neopenda is a public benefit corporation and social enterprise based in Chicago, Illinois, founded in 2015 by Sona Shah and Teresa Cauvel. The company focuses on developing affordable medical technologies tailored for low-resource healthcare settings, particularly in emerging markets like Uganda and Kenya. Their flagship product, neoGuard, is a wearable vital signs monitor for newborns. This device allows healthcare providers in resource-constrained hospitals to continuously track vital signs such as heart rate, respiratory rate, oxygen saturation, and temperature. It alerts nurses when a baby is in distress, facilitating timely interventions to reduce neonatal mortality rates. Neopenda's mission is to decrease preventable newborn deaths by creating innovative and user-friendly medical devices that fill critical gaps in healthcare infrastructure. The company reinvests a significant portion of its profits to enhance its impact, reflecting a commitment to social good alongside financial sustainability. Their team includes experts in the U.S. and field coordinators in Uganda, emphasizing a collaborative approach to product development and clinical validation.

• Employees 14
• Founded 2015
• Annual Revenue $1500000
• Total Funding $3837000